Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 2 , Pages 197-204, March 2010

Clinical significance of the positive surgical margin based upon location, grade, and stage

  • Neil E. Fleshner, M.D., M.P.H., F.R.S.C.S.

      Affiliations

    • Division of Urology, University Health Network and Department of Surgery, University of Toronto, Toronto, Ontario, Canada
    • Corresponding Author InformationCorresponding author. Tel.: +416-946-2899; fax: +416-946-6590
  • ,
  • Andrew Evans, M.D., Ph.D.

      Affiliations

    • Department of Pathology, University Health Network, University of Toronto, Toronto, Ontario, Canada
  • ,
  • Karen Chadwick, M.S.C.

      Affiliations

    • Division of Urology, University Health Network, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
  • ,
  • Nathan Lawrentschuk, M.B., B.S., F.R.A.C.S.

      Affiliations

    • Division of Urology, University Health Network, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
  • ,
  • Alexandre Zlotta, M.D.

      Affiliations

    • Mount Sinai Hospital and Department of Surgery, University of Toronto, Toronto, Ontario, Canada

Abstract 

Prostate cancer remains a challenge due to its incidence and radical prostatectomy continues to be a major treatment option for men with potentially curable disease who have a life expectancy over a decade. This article will address the common problem of positive surgical margins and the impact of them on patient outcome. Through these we can examine relevant clinical trials that have attempted to address this issue and offer some guided to therapy among men with this clinical problem. Close margins are probably of no significance and will not be addressed. Our recommendations take into account the current level of medical evidence, and are balanced with anticipated adverse effects of treatment. They may change over time once definitive clinical trials are completed. In brief we believe those with positive margins and PT2 we advocate close observation with the aim of early salvage radiotherapy if necessary. Those with PT3a and focally positive margins with low/intermediate grade tumors are at moderate risk of biochemical failure so should be managed like PT2 patients. However those with high-grade disease should be offered adjuvant radiotherapy. Similarly those with PT3a margin positive extensive or multiple site disease should have adjuvant radiotherapy. PT3B margin positive patients should be offered radiotherapy. PT4 with bladder neck only margin positive can probably be observed.

Keywords: Prostate neoplasm, Prostatectomy, Urology, Pathology, Operative surgical procedures, Outcome assessment

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1078-1439(09)00268-3

doi:10.1016/j.urolonc.2009.08.015

Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 2 , Pages 197-204, March 2010